Recombinant Humanized Type I/III Collagen (rhCol) via High-Density Pichia pastoris
High-titer precision fermentation of human-identical collagen triple-helix domains in Pichia pastoris, delivering non-immunogenic, virus-free biocompatible collagen for injectable aesthetics and wound healing.
1 · What it gives
Recombinant Humanized Type I/III Collagen (rhCol) via High-Density Pichia pastoris defines the forefront of biofabrication and regenerative medicine, constructing patient-specific, three-dimensional, living tissue constructs or implantable biomaterials capable of anatomical restoration and physiological integration. By integrating computer-aided design (CAD/CAM), stimuli-responsive or biofunctional polymer inks, and live-cell extrusion or light-based stereolithography (SLA/DLP), the platform bridges the gap between synthetic biomaterials and native extracellular matrix (ECM). The technology addresses foundational bottlenecks of microvascular perfusability, mechanical mismatch, and cellular ischemia in thick tissue constructs.
The industrial manufacturing train unites medical-grade biomaterial synthesis (such as recombinant humanized collagen, PCL, PLGA, or gelatin-methacryloyl GelMA), multi-axis pneumatic or digital light processing bioprinters, and dynamic perfusion biomimetic bioreactors. In-line stereomicroscopy and optical coherence tomography (OCT) ensure sub-20 um spatial resolution across multi-layered constructs. Fabricated tissue grafts undergo dynamic mechanical conditioning (pulsatile flow, cyclical stretch) to accelerate ECM deposition, maturation, and functional endothelialization before preclinical or clinical transplantation.
The key directions of this technology are:
- Biomimetic Bioink Chemistry & Rheology in Recombinant Humanized Type I/III Collagen (rhCol) via High-Density Pichia pastoris: Engineering shear-thinning hydrogels with rapid post-extrusion photo-crosslinking (e.g., LAP photoinitiator with 405 nm visible light) to maintain high shape fidelity and >90% cell viability.
- Sacrificial Pluronic / Gelatin Microvascular Channeling: Utilizing thermally reversible sacrificial fugitive inks to pattern interconnected hierarchical vascular networks within centimeter-scale tissue volumes.
- Biomimetic Perfusion Conditioning Bioreactors: Applying physiological pulsatile shear stress and cyclic strain to stimulate smooth muscle and endothelial cell alignment, accelerating vascular graft maturation.
- Biomaterial Biodegradation & Mechanical Mechanics Control: Tailoring polymer molecular weights and crosslinking densities to synchronize scaffold degradation kinetics with native ECM neo-synthesis in vivo.
Sectoral value chain#
┌────────────────────────────────────────────────────────┐
│ Tier 1: Medical-Grade Biomaterial & Bioink Synthesis │
│ (rhCollagen, GelMA, LAP photoinitiator, cell seeding) │
└───────────────────────────────────┬────────────────────┘
│
▼
┌────────────────────────────────────────────────────────┐
│ Tier 2: Patient Anatomical CAD Modeling & Slicing │
│ (CT/MRI 3D reconstruction, G-code toolpath routing) │
└───────────────────────────────────┬────────────────────┘
│
▼
┌────────────────────────────────────────────────────────┐
│ Tier 3: Multi-Material Bioprinting & Crosslinking │
│ (Pneumatic extrusion/DLP, visible light photocuring) │
└───────────────────────────────────┬────────────────────┘
│
▼
┌────────────────────────────────────────────────────────┐
│ Tier 4: Dynamic Perfusion Maturation Bioreactor │
│ (Pulsatile flow, mechanical stretch, endothelization) │
└───────────────────────────────────┬────────────────────┘
│
▼
┌────────────────────────────────────────────────────────┐
│ Tier 5: Mechanical, Histological & Sterile Release QC │
│ (Tensile burst pressure, suture retention, ISO 10993) │
└────────────────────────────────────────────────────────┘
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| Biomaterial Precursor Synthesis | Precision synthesis and endotoxin purification of clinical-grade bioinks and synthetic polymers. | In: Raw gelatin/PCL, methacrylic anhydride, LAP, WFI. Out: Endotoxin-tested, sterile-filtered bioink components (<0.5 EU/mL). |
| Anatomical Modeling & Toolpath Slicing | Translating patient DICOM volumetric scans into multi-layered toolpaths optimized for printability. | In: Patient CT/MRI imaging data, CAD/CAM slicing software. Out: Validated numerical G-code routines for multi-nozzle bioprinting. |
| Robotic Bioprinting & Photopolymerization | Deposition of living cell-laden inks and structural polymers followed by controlled 405 nm photo-curing. | In: Cell-laden bioink, sacrificial ink, multi-head bioprinter. Out: Structurally coherent, vascularized multi-tissue constructs. |
| Perfusion Bioreactor Tissue Maturation | Culturing constructs under dynamic pulsatile flow and physiological strain to promote native ECM remodeling. | In: Printed constructs, specialized bioreactor chambers, media. Out: Matured living tissue graft with continuous patent lumens. |
| Biomechanical & Biological Release Testing | Comprehensive validation of tensile modulus, suture retention strength, cell viability, and sterility. | In: Mature graft specimens, mechanical testing fixtures. Out: Fully released, clinical-transplantation grade tissue implant. |
Cross-cutting technologies of the sector:
- Optical Coherence Tomography (OCT) Metrology: Real-time non-destructive volumetric scanning verifying internal lumen patency and wall thickness.
- Biaxial Mechanical & Burst Pressure Testing: Ensuring engineered vascular conduits and soft tissues withstand arterial hemodynamic pressures (>1500 mmHg).
2 · What it replaces 3 · matched by industry
| D1E– | Fermentation cosmetic ingredients instead of shark-liver squalene, rooster-comb hyaluronic acid and animal collagen Replaces: Shark-liver oil squalene (deep-sea shark fisheries); hyaluronic acid from rooster combs; bovine/porcine collagen extracts (and their … | COSM |
| D3E2 | Biodegradable scrub particles and exfoliants instead of polyethylene microbeads Replaces: Polyethylene (and PP/PET/PMMA) microbeads in rinse-off cosmetics: face/body scrubs, toothpastes, shower gels; glitter (polyester/alu … | COSM |
| D1E– | Biosurfactant and APG cleansing — sophorolipids, rhamnolipids, alkyl polyglucosides — instead of petrochemical SLES/SLS Replaces: Petrochemical anionic surfactants (SLES/SLS) and their ethoxylated feedstock chain (1,4-dioxane contamination risk at trace levels, … | COSM |
3 · How to implement 4 steps
- 1Human COL3A1/COL1A1 codon optimizationSynthesizing high-affinity integrin-binding triple-helix sequence optimized for Pichia pastoris.
- 2High-cell-density fed-batch fermentationFermentation & cultivationMethanol-induced fermentation in 50kL stainless fermenters secreting soluble rhCol into broth.
- 3Chromatographic downstream purificationPurification & downstreamHydrophobic interaction and ion exchange chromatography removing yeast host cell proteins to >99.9% purity.
- 4Medical hydrogel formulationFormulation & blendingFormulating sterile injectable hydrogels and dermal dressings with zero risk of animal zoonotic viruses.
4 · Who delivers
Matched suppliers (matched automatically)
| Jiangsu Jland Biotech | China | Producer | active |
| Bloomage Biotechnology | China | Distributor | active |
| Jiangsu Trautec | China | Producer | active |
| Giant Biogene Holding | China | Distributor | active |
| UMAMI Bioworks | Singapore | Producer | active |
| Biopolytech Co., Ltd. | South Korea | Producer | active |
| Aleph Farms | Israel | Producer | active |
| Zero Cow Factory | India | Producer | active |
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| CollPlant Biotechnologies | 🇮🇱 Israel | Plant-Derived Recombinant Human rhCollagen Bioinks | Standardized cGMP ATMP bioprocess module and validated analytical release assay suite. | Commercial / Approved |
| Miltenyi Biotec | 🇩🇪 Germany | CliniMACS Prodigy Automated Processing | Standardized cGMP ATMP bioprocess module and validated analytical release assay suite. | Commercial / Approved |
| Lonza Cell & Gene | 🇨🇭 Switzerland | Cocoon Closed Manufacturing Platform | Standardized cGMP ATMP bioprocess module and validated analytical release assay suite. | Commercial / Approved |
| Cytiva | 🇺🇸 United States | Xuri Cell Expansion Bioreactors & Sefia | Standardized cGMP ATMP bioprocess module and validated analytical release assay suite. | Commercial / Approved |
| WuXi Advanced Therapies | 🇨🇳 China | Viral Vector Testing & Analytical Development | Standardized cGMP ATMP bioprocess module and validated analytical release assay suite. | Commercial / Approved |
| Sartorius Stedim Biotech | 🇩🇪 Germany | Ambr Bioreactors & Process PAT Systems | Standardized cGMP ATMP bioprocess module and validated analytical release assay suite. | Commercial / Approved |
| Thermo Fisher Scientific | 🇺🇸 United States | Gibco CTS Cell Therapy Media | Standardized cGMP ATMP bioprocess module and validated analytical release assay suite. | Commercial / Approved |
5 · Rules & route to market
declaration (SGR for some categories)
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States
FDA CDRH/CBER combination product pathways, ARMI BioFab, ISO 10993#
- FDA Combination Product Guidelines: Jurisdictional oversight for Recombinant Humanized Type I/III Collagen (rhCol) via High-Density Pichia pastoris navigating drug-device or biologic-device designations between CBER and CDRH.
- ARMI BioFabUSA Manufacturing Consortia: National manufacturing institute standardizing modular automated biofabrication cleanroom systems.
- ISO 10993 Biocompatibility Testing: Rigorous preclinical evaluation of cytotoxicity, genotoxicity, systemic toxicity, and hemocompatibility.
European Union
EU Medical Device Regulation (MDR 2017/745), Swissmedic standards#
- EU MDR Rule 8 / Rule 18 Compliance: Strict conformity assessment for implantable medical devices incorporating tissues or cells of human/animal origin.
- European Bioprinting Hubs: Advanced collaborative research centers across Switzerland (ETH Zürich), Germany (Fraunhofer), and the Netherlands.
- CE Marking Clinical Data Requirements: Comprehensive clinical evaluation reports verifying long-term tissue remodeling and integration safety.
China
NMPA Class III medical device approvals, national 3D printing centers#
- NMPA Priority Review for Innovative Devices: Fast-track clinical review channels for 基于高密度毕赤酵母工程发酵表达的重组人源化I/III型胶原蛋白 (rhCol) under Class III implantable medical device pathways.
- National Biomanufacturing Centers: State key laboratories in Tsinghua, Zhejiang University, and Shanghai Jiao Tong accelerating clinical translation.
- Regional Medical Device Industrial Parks: High-density clusters in Changzhou, Suzhou, and Shenzhen supplying medical-grade biodegradable polymers.
6 · Money: tenders & grants
No open tender or grant matched right now.
7 · Tech stack & innovations
- Functional Bioink Formulation in Recombinant Humanized Type I/III Collagen (rhCol) via High-Density Pichia pastoris:
- Recombinant humanized collagen or modified gelatin matrices with defined methacrylation degrees.
- Non-toxic visible-light photoinitiators (LAP) providing rapid crosslinking under low-intensity 405 nm irradiation.
- High-Precision Multi-Head Biofabrication:
- Pneumatic extrusion printheads coupled with temperature-controlled peltier nozzles.
- Laser-assisted or digital light processing (DLP) projections achieving sub-25 um feature resolution.
- Dynamic Biomimetic Tissue Bioreactors:
- Continuous multichannel peristaltic perfusion circuits delivering oxygenated nutrient flow directly through lumen architectures.
- Programmable mechanical actuators delivering cyclical uniaxial or radial stretch to condition structural cells.
Sources 5 · 2 independent · 3 producer sites
Independent sources 2
- doi.org research checked 2026-11-15
- xueqiu.com website checked 2026-11-15
Producers' own sites 3
- Giant biogene 02367hk producer checked 2026-11-15 · link not kept
- Bloomage biotech producer checked 2026-11-15 · link not kept
- Trautec producer checked 2026-11-15 · link not kept